Keros Therapeutics (KROS) Net Income (QoQ) (2019 - 2025)
Keros Therapeutics (KROS) Net Income (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 472.40 Bn | 467.61 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.23 Bn | 114.98 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.29 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.46 Bn | 62.46 Bn | - |
| 8 | Argenx Se | 55.94 Bn | 50.76 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn |
| 10 | Keros Therapeutics | 384.12 Mn | 96.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -222.27% |
| Sep 30, 2025 | 76.28% |
| Jun 30, 2025 | -120.68% |
| Mar 31, 2025 | 422.54% |
| Dec 31, 2024 | 13.09% |
| Sep 30, 2024 | -17.01% |
| Jun 30, 2024 | -4.97% |
| Mar 31, 2024 | 5.40% |
| Dec 31, 2023 | 40.72% |
| Sep 30, 2023 | 15.92% |
| Jun 30, 2023 | -132.26% |
| Mar 31, 2023 | -32.48% |
| Dec 31, 2022 | -26.41% |
| Sep 30, 2022 | 13.78% |
| Jun 30, 2022 | -12.73% |
| Mar 31, 2022 | -248.50% |
| Dec 31, 2021 | 65.81% |
| Sep 30, 2021 | -29.93% |
| Jun 30, 2021 | 1.66% |
| Mar 31, 2021 | -48.79% |